Harlan W. Waksal
2017 - Kadmon Holdings
In 2017, Harlan W. Waksal earned a total compensation of $2.6M as President and Chief Executive Officer at Kadmon Holdings, a 81% decrease compared to previous year.
Compensation breakdown
| Bonus | $500,000 |
|---|---|
| Option Awards | $1,584,124 |
| Salary | $500,000 |
| Other | $23,575 |
| Total | $2,607,699 |
Waksal received $1.6M in option awards, accounting for 61% of the total pay in 2017.
Waksal also received $500K in bonus, $500K in salary and $23.6K in other compensation.
Rankings
In 2017, Harlan W. Waksal's compensation ranked 4,261st out of 14,666 executives tracked by ExecPay. In other words, Waksal earned more than 70.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,261 out of 14,666 | 71st |
Division Manufacturing | 1,493 out of 5,770 | 74th |
Major group Chemicals And Allied Products | 427 out of 2,074 | 79th |
Industry group Drugs | 328 out of 1,730 | 81st |
Industry Pharmaceutical Preparations | 261 out of 1,329 | 80th |
Source: SEC filing on June 15, 2018.
Waksal's colleagues
We found two more compensation records of executives who worked with Harlan W. Waksal at Kadmon Holdings in 2017.
News
Lyra Therapeutics Chairman Harlan Waksal receives $5M in 2022
April 25, 2023
Kadmon Holdings CFO Steven Meehan's 2020 pay jumps 76% to $2.3M
April 1, 2021
Kadmon Holdings CEO Harlan Waksal's 2019 pay jumps 27% to $4.7M
April 2, 2020
Kadmon Holdings CEO Harlan Waksal's 2018 pay jumps 43% to $3.7M
April 2, 2019